In an elderly patient (>60 years) with bradykinesia, rigidity, and gait disturbance, how can I differentiate progressive supranuclear palsy (PSP) from Parkinson disease (PD) and determine the appropriate initial management?

Differentiating PSP from Parkinson Disease

Look for early falls, vertical gaze abnormalities, and axial rigidity with poor levodopa response to identify PSP, while resting tremor, asymmetric onset, and good levodopa response point to Parkinson disease.

Key Clinical Distinguishing Features

Progressive Supranuclear Palsy (PSP) Red Flags

PSP typically presents in the sixth or seventh decade (mean age 63) with distinctive features that should raise immediate suspicion 1:

• Early falls and postural instability - This is the hallmark presentation, often manifesting as a "lurching gait" and unexplained falls within the first year of symptom onset 2
• Vertical supranuclear gaze palsy - While this classic finding may appear later in disease, early ocular symptoms include blurred vision, slow saccades, square wave jerks, and eyelid opening apraxia 1, 3
• Axial rigidity predominates over limb rigidity, with neck dystonia and upper trunk stiffness 4
• Symmetric onset of symptoms 5
• Absence of resting tremor 2
• Poor or absent response to levodopa 4, 2, 3
• Pseudobulbar features - dysphagia, dysarthria 4
• Frontal executive dysfunction appearing early 1

Parkinson Disease Features

PD presents with a distinct pattern 1:

• Resting tremor - often the initial and dominant feature
• Asymmetric onset - symptoms typically begin unilaterally
• Good initial response to levodopa - this is critical for differentiation
• Falls occur late in disease course, not early
• Slower progression compared to PSP

Quantitative Gait Analysis Findings

Recent high-quality evidence demonstrates specific gait patterns that distinguish these conditions even in early stages 6, 7:

PSP gait characteristics:

• Longer stance phase
• Increased double-support time
• Increased mediolateral sway
• Reduced stride length and gait speed
• Reduced trunk range of motion

PD gait characteristics:

• Increased cadence
• Longer cycle length
• Better preserved gait velocity early on

Diagnostic Imaging Approach

First-Line: MRI Brain Without Contrast

MRI is the optimal initial imaging modality 1. Look for these PSP-specific findings 8, 3:

• Midbrain atrophy producing the "hummingbird sign" (sagittal view) and "Mickey Mouse sign" (axial view)
• Reduced midbrain area and midbrain-to-pons (M/P) ratio
• Increased cerebral interpeduncular angle (sensitivity 100%, specificity 90% for PSP)
• Elevated Magnetic Resonance Parkinsonism Index (MRPI) (sensitivity 88.9%, specificity 100% for PSP)
• Reduced superior cerebellar peduncle (SCP) width

In contrast, PD typically shows normal structural MRI early in disease, though susceptibility-weighted imaging may demonstrate the "swallow tail" sign in the dorsolateral substantia nigra 1.

Functional Imaging

I-123 Ioflupane (DaTscan) SPECT/CT is valuable for confirming a Parkinsonian syndrome but cannot differentiate PSP from PD - both show decreased dopamine transporter binding 1. A normal scan essentially excludes both conditions.

FDG-PET/CT can distinguish PSP from PD 1:

• PSP pattern: Hypometabolism in medial frontal cortex, anterior cingulate, striatum, and midbrain
• PD: Does not show this typical metabolic pattern

Clinical Diagnostic Algorithm

Step 1: Assess the temporal pattern of falls

• Falls within first year + gait instability → strongly favor PSP 2
• Falls occurring late in disease → favor PD

Step 2: Examine eye movements carefully

• Vertical gaze palsy (especially upward), slow saccades, square wave jerks → PSP 2, 3
• Normal eye movements early → PD

Step 3: Evaluate symmetry and tremor

• Symmetric onset + absent tremor → PSP 2, 5
• Asymmetric onset + resting tremor → PD

Step 4: Trial of levodopa

• No response or minimal response → PSP 4, 2
• Moderate to good response → PD

Step 5: Obtain MRI brain

• Midbrain atrophy with hummingbird sign, elevated MRPI → confirms PSP 8, 3
• Normal structural imaging → supports PD

PSP Variant Consideration

Be aware that PSP-Parkinsonism (PSP-P) can initially mimic PD with asymmetric onset, tremor, and moderate initial levodopa response 5. However, PSP-P evolves over time to show typical PSP features including falls, gaze abnormalities, and loss of levodopa responsiveness. This variant has a more favorable prognosis (8-12 years survival) compared to classic PSP-Richardson syndrome (5-7 years) 9.

Initial Management Approach

For PSP:

• Trial levodopa despite expected poor response, especially in parkinsonian phenotypes - some patients show modest benefit 4
• Focus on fall prevention strategies and physical therapy given early postural instability
• Multidisciplinary approach with speech therapy for dysphagia/dysarthria
• Set realistic expectations: PSP progresses more rapidly than PD with median survival 5-7 years for classic Richardson syndrome 9

For PD:

• Initiate levodopa therapy - expect good symptomatic response
• Physical therapy and exercise programs
• Better long-term prognosis with slower progression

Critical Pitfalls to Avoid

1. Don't rely solely on vertical gaze palsy - this classic sign often appears later in PSP, not at presentation 1, 4
2. Don't dismiss PSP if there's initial levodopa response - PSP-P variant can show moderate early response 5
3. Don't order CT as initial imaging - it has limited soft-tissue characterization and may miss early PSP changes 1
4. Don't assume asymmetric presentation rules out PSP - PSP-P can present asymmetrically 5
5. Early falls are the most reliable early differentiator - this single feature within the first year has the highest discriminatory value 2, 6